| 000 | 01645 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514015335.0 | ||
| 264 | 0 | _c20020227 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a0742-3098 | ||
| 024 | 7 |
_a10.1034/j.1600-079x.2001.310408.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSkene, D J | |
| 245 | 0 | 0 |
_aContribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices. _h[electronic resource] |
| 260 |
_bJournal of pineal research _cNov 2001 |
||
| 300 |
_a333-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzoflavones _xpharmacology |
| 650 | 0 | 4 |
_aChlorzoxazone _xpharmacology |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP1A2 _xmetabolism |
| 650 | 0 | 4 | _aCytochrome P-450 CYP1A2 Inhibitors |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelatonin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xmetabolism |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aNADP _xmetabolism |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aTheophylline _xanalogs & derivatives |
| 700 | 1 | _aPapagiannidou, E | |
| 700 | 1 | _aHashemi, E | |
| 700 | 1 | _aSnelling, J | |
| 700 | 1 | _aLewis, D F | |
| 700 | 1 | _aFernandez, M | |
| 700 | 1 | _aIoannides, C | |
| 773 | 0 |
_tJournal of pineal research _gvol. 31 _gno. 4 _gp. 333-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1034/j.1600-079x.2001.310408.x _zAvailable from publisher's website |
| 999 |
_c11618781 _d11618781 |
||